PCK submits application for Adult App FDA De Novo clearance
Filed with ASX · · 3 pages · English
Story so far
Earlier from PainChek
- PCK expands market reach with BESTMED reseller agreement
- Positive study results pave way for PainChek FDA submission
- PainChek Adult app FDA De Novo submission update
- PainChek receives European patent for pain assessment tech
- PainChek receives $1,210,000 R&D Tax Incentive Refund
Later from PainChek
- Underwritten Entitlement Offer to raise AUD $5.1million
- Prospectus
- PainChek Implementations, Market and International Expansion
- PainChek completes Entitlement Offer raising AUD $5.1 m
- R&D Tax Refund, FDA Review of Adult App & Infant App Launch
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek